Publications

Strict data privacy laws like the GDPR have significantly reduced biopharmaceutical R&D investment—especially among smaller firms—highlighting the need for U.S. policymakers to reform HIPAA, pass innovation-friendly federal privacy legislation, and invest in privacy-enhancing technologies to protect both privacy and progress in medical research.

The EU’s overbroad interoperability mandates target U.S. tech firms, delay new features for European users, and open the door for China to challenge Western tech leadership.

America’s wireless future depends on efficient spectrum use—and unlocking more federal airwaves for commercial innovation will strengthen both the economy and national security.

The collapse of a UK espionage case against alleged Chinese spies highlights Britain’s refusal to call China a security threat, exposing a dangerous weakness driven by economic dependence.

If Senator Sanders wants to raise wages, he should focus on the real cause of slow growth, lagging productivity from low capital investment, instead of stymieing AI.

This merger will be a win for consumers and regulators should not stand in the way.

Asians earn bachelor’s degrees in STEM fields at much higher rates than other racial and ethnic groups, strengthening the United States’ innovation capacity, industrial base, and global competitiveness. Their academic success is an asset that should be rewarded, not penalized.

A new proposal to tax university patent royalties would do little to benefit taxpayers while undermining the Bayh-Dole system that drives U.S. innovation, risking America’s global leadership in turning research into real-world breakthroughs.

Korea has entered the global top four economies in innovation, powered by world-class research intensity and corporate R&D. Amid a persistent input–output gap and weak startup M&A activity, the challenge now is scale: converting knowledge into globally competitive firms.

Compared to the United States, venture capital (VC) activity in the European Union (EU) is low, with EU-headquartered firms receiving $1.4 trillion less VC funding than their American counterparts from 2013 to 2022.